1. Home
  2. ATOS vs ESP Comparison

ATOS vs ESP Comparison

Compare ATOS & ESP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATOS
  • ESP
  • Stock Information
  • Founded
  • ATOS 2009
  • ESP 1928
  • Country
  • ATOS United States
  • ESP United States
  • Employees
  • ATOS N/A
  • ESP 148
  • Industry
  • ATOS Biotechnology: Pharmaceutical Preparations
  • ESP Industrial Machinery/Components
  • Sector
  • ATOS Health Care
  • ESP Technology
  • Exchange
  • ATOS Nasdaq
  • ESP Nasdaq
  • Market Cap
  • ATOS 112.5M
  • ESP 129.5M
  • IPO Year
  • ATOS 2012
  • ESP N/A
  • Fundamental
  • Price
  • ATOS $0.85
  • ESP $48.50
  • Analyst Decision
  • ATOS Strong Buy
  • ESP
  • Analyst Count
  • ATOS 3
  • ESP 0
  • Target Price
  • ATOS $6.17
  • ESP N/A
  • AVG Volume (30 Days)
  • ATOS 1.5M
  • ESP 32.9K
  • Earning Date
  • ATOS 08-11-2025
  • ESP 05-12-2025
  • Dividend Yield
  • ATOS N/A
  • ESP 2.11%
  • EPS Growth
  • ATOS N/A
  • ESP 39.20
  • EPS
  • ATOS N/A
  • ESP 2.67
  • Revenue
  • ATOS N/A
  • ESP $45,965,588.00
  • Revenue This Year
  • ATOS N/A
  • ESP N/A
  • Revenue Next Year
  • ATOS N/A
  • ESP N/A
  • P/E Ratio
  • ATOS N/A
  • ESP $17.39
  • Revenue Growth
  • ATOS N/A
  • ESP 29.60
  • 52 Week Low
  • ATOS $0.55
  • ESP $20.50
  • 52 Week High
  • ATOS $1.66
  • ESP $48.71
  • Technical
  • Relative Strength Index (RSI)
  • ATOS 51.17
  • ESP 73.43
  • Support Level
  • ATOS $0.81
  • ESP $44.48
  • Resistance Level
  • ATOS $0.92
  • ESP $48.71
  • Average True Range (ATR)
  • ATOS 0.05
  • ESP 1.81
  • MACD
  • ATOS -0.00
  • ESP 0.27
  • Stochastic Oscillator
  • ATOS 52.73
  • ESP 72.92

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

About ESP Espey Mfg. & Electronics Corp.

Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.

Share on Social Networks: